Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Invivyd, Inc.
  6. Consensus
    IVVD   US00534A1025

INVIVYD, INC.

(IVVD)
  Report
Delayed Nasdaq  -  04:00:01 2023-02-07 pm EST
2.040 USD   +0.99%
02/03Invivyd Announces Changes to Executive Team
GL
02/03Invivyd, Inc. Announces Executive Changes
CI
01/24Morgan Stanley Trims Invivyd Price Target to $2 From $3, Maintains Underweight Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Evolution of the average Target Price on INVIVYD, INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) INVIVYD, INC.
Analyst Recommendations on INVIVYD, INC.
01/24Morgan Stanley Trims Invivyd Price Target to $2 From $3, Maintains Underweight Rating
MT
2022Stifel Adjusts Adagio Therapeutics' Price Target to $5 From $9, Reiterates Hold Rating
MT
2022Morgan Stanley Downgrades Adagio Therapeutics to Underweight Rating From Equalweight, Adju..
MT
2021Jefferies Downgrades Adagio Therapeutics to Hold From Buy; Price Target is $10
MT
2021Morgan Stanley Downgrades Adagio Therapeutics to Equalweight from Overweight, Adjusts Pric..
MT
2021Guggenheim Downgrades Adagio Therapeutics to Neutral From Buy
MT
2021Stifel Downgrades Adagio Therapeutics to Hold From Buy, Adjusts Price Target to $9 From $5..
MT
More recommendations
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 3
Last Close Price 2,04 $
Average target price 2,75 $
Spread / Average Target 34,8%
High Price Target 3,50 $
Spread / Highest target 71,6%
Low Price Target 2,00 $
Spread / Lowest Target -1,96%
Consensus detail
Consensus revision (last 18 months)